ROSG

Rosetta Genomics Ltd. Press Releases

$3.162
*  
0.042
1.35%
Get ROSG Alerts
*Delayed - data as of Jul. 29, 2015 11:01 ET  -  Find a broker to begin trading ROSG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ROSG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Rosetta Genomics Expands High-Value Molecular Diagnostic Offering with Launch of OncoGxSelect™
7/28/2015 8:00:00 AM - Business Wire
▲4.36 % Price Change since this news event. The Volume Ratio is 10.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Rosetta Genomics Files Pro Forma Financials in Connection with PersonalizeDx Acquisition
7/8/2015 5:38:00 PM - Business Wire
▲4.36 % Price Change since this news event. The Volume Ratio is 0.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Announces Participation in Cantor Fitzgerald’s Inaugural “From Bench to Bedside” Healthcare Conference
7/1/2015 8:00:00 AM - Business Wire
▼-6.73 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services
6/16/2015 8:30:00 AM - Business Wire
▼-8.08 % Price Change since this news event. The Volume Ratio is 5.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Launches OncoGxOne™
5/28/2015 9:06:00 AM - Business Wire
▼-15.45 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Announces Selection of First Pilot Project Grant under Strategic Alliance with Moffitt Cancer Center
5/26/2015 9:00:00 AM - Business Wire
▼-17.66 % Price Change since this news event. The Volume Ratio is 3.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Launches Two Assays for Bladder Cancer
5/14/2015 8:48:00 AM - Business Wire
▼-17.87 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rosetta Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test™
5/13/2015 9:07:00 AM - Business Wire
▼-19.75 % Price Change since this news event. The Volume Ratio is 5.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Data on Rosetta Genomics’ Novel Thyroid Nodule Classification Assay to be Presented at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress
5/12/2015 8:23:00 AM - Business Wire
▼-18.29 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day